Marvel Studios
The next film licensed from Marvel Studios was "Spider-Man" by Columbia Pictures, directed by Sam Raimi and starring Tobey Maguire as Spider-Man. The film was released on May 3, 2002, grossing $403,706,375 in the United States and Canada and $821,708,551 worldwide. The early success of "Spider-Man" led the film's studio to issue a seven-figure advance for a sequel. Arad spoke of the deal, "Movies make sequels. Therefore, it's a big economic luxury to know that a movie's going to get a second and third. This is a business of precedence." According to a Lehman Brothers analysis, the Studios made only $62 million for the first 2 Spider-Man movies. Marvel was making more from half the consumer product licensing fees while making relatively little from the movie, but was enough for Marvel to regain its financial footings. In October 2002, Marvel Studios announced deals for Sub-Mariner and Prime with Universal Studios.
Morbius, the Living Vampire
Morbius debuted in "The Amazing Spider-Man" #101 (cover-dated Oct. 1971) following the February 1971 updating of the comic-book industry's self-censorship board, the Comics Code Authority, that lifted a ban on vampires and certain other supernatural characters. It was the first issue of Marvel Comics' flagship "Spider-Man" series written by someone other than character co-creator and editor-in-chief Stan Lee. Lee, busy writing a screenplay for an unproduced science fiction movie, bequeathed the series to his right-hand editor, Roy Thomas. "We were talking about doing Dracula, but Stan wanted a costumed villain. Other than that, he didn't specify what we should do," Thomas said in 2009, adding that part of the character conception came from an unspecified science-fiction film of Thomas' youth, depicting a man turned into a vampire by radiation rather than magic. Thomas said that the name "Morbius" was not deliberately taken from the antagonist Doctor Morbius in the movie "Forbidden Planet".